GALAPAGOS NV - Ordinary shares, no par value (GLPG)

Historical Holders from Q2 2015 to Q3 2025

Symbol
GLPG on Nasdaq
Type / Class
Equity / Ordinary shares, no par value
Shares outstanding
66,186,595
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
31,401,256
Holdings value
$1,087,732,117
% of all portfolios
0%
Number of holders
92
Number of buys
48
Number of sells
-40
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GALAPAGOS NV - Ordinary shares, no par value (GLPG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GILEAD SCIENCES, INC. 30% $555,786,955 20,981,010 Gilead Sciences, Inc. 07 Jan 2025
EcoR1 Capital, LLC 13% +12% $243,919,471 +$25,507,847 8,714,522 +12% EcoR1 Capital, LLC 24 Jul 2025
TANG CAPITAL MANAGEMENT LLC 8.4% +11% $192,587,107 +$22,486,521 5,559,674 +13% TANG CAPITAL MANAGEMENT, LLC 27 Oct 2025

Institutional Holders of GALAPAGOS NV - Ordinary shares, no par value (GLPG)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 31,401,256 $1,087,732,117 -$7,956,750 $34.64 92
2025 Q2 31,697,765 $887,221,465 +$28,214,019 $27.99 85
2025 Q1 31,070,295 $780,194,528 -$4,334,186 $25.12 82
2024 Q4 31,079,138 $856,919,857 +$17,773,347 $27.50 81
2024 Q3 13,663,353 $393,374,763 -$177,023,110 $28.79 77
2024 Q2 19,935,693 $494,012,131 -$14,463,813 $24.78 82
2024 Q1 20,486,366 $659,634,802 +$21,269,889 $32.20 79
2023 Q4 19,790,623 $804,487,651 +$20,616,236 $40.65 87
2023 Q3 19,171,399 $662,382,310 -$16,486,115 $34.55 72
2023 Q2 19,708,613 $801,351,937 +$60,840,835 $40.66 73
2023 Q1 18,215,508 $703,834,822 +$192,041,792 $38.64 72
2022 Q4 13,177,559 $584,821,554 +$12,983,412 $44.38 71
2022 Q3 12,911,798 $550,549,123 -$12,978,528 $42.64 77
2022 Q2 12,900,644 $719,839,590 -$9,312,560 $55.80 79
2022 Q1 12,830,797 $795,810,983 +$134,250,057 $62.02 86
2021 Q4 10,793,402 $595,046,185 +$111,349,568 $55.13 81
2021 Q3 8,551,124 $449,836,824 +$478,944 $52.61 80
2021 Q2 7,506,771 $517,197,342 +$62,993,693 $68.89 99
2021 Q1 6,565,519 $505,977,352 +$131,911,497 $77.09 123
2020 Q4 4,564,667 $452,130,046 -$397,947,991 $98.98 106
2020 Q3 7,422,842 $1,053,286,217 -$44,029,693 $141.91 116
2020 Q2 7,628,171 $1,504,806,578 -$6,418,127 $197.29 138
2020 Q1 7,635,004 $1,496,203,411 +$21,392,001 $195.92 134
2019 Q4 7,536,405 $1,559,270,022 -$160,871,419 $206.83 131
2019 Q3 8,452,122 $1,290,298,392 -$17,782,663 $152.66 107
2019 Q2 8,609,689 $1,109,988,146 +$27,460,569 $128.92 97
2019 Q1 8,434,206 $992,909,447 +$41,282,212 $117.78 90
2018 Q4 8,129,846 $745,897,773 -$131,705,602 $91.74 83
2018 Q3 9,418,445 $1,058,490,000 +$209,124,789 $112.43 92
2018 Q2 7,571,432 $698,237,000 -$137,754,779 $92.18 75
2018 Q1 8,967,419 $894,285,000 -$95,785,246 $99.76 81
2017 Q4 9,935,364 $931,537,469 -$14,984,765 $93.76 73
2017 Q3 10,094,449 $1,027,153,000 -$183,787,937 $101.75 68
2017 Q2 12,053,183 $922,291,000 +$147,875,279 $76.52 77
2017 Q1 10,067,404 $867,877,000 +$7,588,646 $86.19 62
2016 Q4 9,985,219 $641,996,000 +$17,885,017 $64.19 50
2016 Q3 9,710,778 $627,740,000 -$5,079,471 $64.66 47
2016 Q2 9,791,859 $542,969,000 +$57,629,593 $55.47 38
2016 Q1 8,766,614 $366,590,000 +$15,263,420 $41.82 32
2015 Q4 8,237,090 $517,944,000 -$28,678,609 $62.88 43
2015 Q3 9,048,062 $368,347,081 +$6,558,839 $40.71 37
2015 Q2 8,787,080 $452,549,000 +$452,549,000 $51.50 40